Evidence map›Paper›PMID 27681749›Full record

ArticleInternational journal of radiation oncology, biology, physics2016

Stereotactic Body Radiation Therapy Delivery in a Genetically Engineered Mouse Model of Lung Cancer.

Shisuo Du, Virginia Lockamy, Lin Zhou, Christine Xue, Justin LeBlanc, Shonna Glenn, Gaurav Shukla, Yan Yu, Adam P Dicker, Dennis B Leeper and 2 more

Abstract read
In one paragraph

Article in International journal of radiation oncology, biology, physics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Oncoimmunology Meets Organs-on-Chip.Frontiers in molecular biosciences · 2021
    Review
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Shisuo DuDepartment of Radiation Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania.
Virginia LockamyDepartment of Radiation Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania.
Lin ZhouDepartment of Thoracic Oncology, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Christine XueDepartment of Radiation Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania.
Justin LeBlancDepartment of Radiation Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania.
Shonna GlennXstrahl, Inc, Suwanee, Georgia.
Gaurav ShuklaDepartment of Radiation Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania.
Yan YuDepartment of Radiation Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania.
Adam P DickerDepartment of Radiation Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania.
Dennis B LeeperDepartment of Radiation Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania.
You LuDepartment of Thoracic Oncology, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Bo LuDepartment of Radiation Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania. Electronic address: bo.lu@jefferson.edu.

Funding

Small Animal Cone Beam CT Guided X-Irradiation System (SARRP)S10OD018171 · OD · THOMAS JEFFERSON UNIVERSITY · PI LU, BO · 2014 to 2014
$600k
Role of PD-1/PDL-1 in Lung Carcinogenesis and TherapyR21CA178229 · NCI · THOMAS JEFFERSON UNIVERSITY · PI LU, BO · 2013 to 2014
$366k
NCI NIH HHS R21 CA178229NIH HHS S10 OD018171
6 · The paper itself

Abstract

purposeTo implement clinical stereotactic body radiation therapy (SBRT) using a small animal radiation research platform (SARRP) in a genetically engineered mouse model of lung cancer. METHODS AND MATERIALS: A murine model of multinodular Kras-driven spontaneous lung tumors was used for this study. High-resolution cone beam computed tomography (CBCT) imaging was used to identify and target peripheral tumor nodules, whereas off-target lung nodules in the contralateral lung were used as a nonirradiated control. CBCT imaging helps localize tumors, facilitate high-precision irradiation, and monitor tumor growth. SBRT planning, prescription dose, and dose limits to normal tissue followed the guidelines set by RTOG protocols. Pathologic changes in the irradiated tumors were investigated using immunohistochemistry.

resultsThe image guided radiation delivery using the SARRP system effectively localized and treated lung cancer with precision in a genetically engineered mouse model of lung cancer. Immunohistochemical data confirmed the precise delivery of SBRT to the targeted lung nodules. The 60 Gy delivered in 3 weekly fractions markedly reduced the proliferation index, Ki-67, and increased apoptosis per staining for cleaved caspase-3 in irradiated lung nodules.

conclusionsIt is feasible to use the SARRP platform to perform dosimetric planning and delivery of SBRT in mice with lung cancer. This allows for preclinical studies that provide a rationale for clinical trials involving SBRT, especially when combined with immunotherapeutics.

Indexed as

Disease Models, AnimalAnimalsAnimals, Genetically ModifiedEquipment DesignEquipment Failure AnalysisLung NeoplasmsMiceRadiosurgeryRadiotherapy DosageRadiotherapy, Image-GuidedTomography, X-Ray ComputedTreatment Outcome

Identifiers

PMID27681749
PMCPMC5380923

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.